| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $0.1723 (Beat by $0.1823) |
| EPS GAAP Actual | $0.1723 (Beat by $0.1823) |
| Revenue Actual | $0.115076B |
| Revenue Surprise | Beat by $115.076M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.2416 |
| EPS GAAP Estimate | $0.2416 |
| Revenue Estimate | $0.0858415B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 0.5 | 16.53 | 0.4635 | 0.52376 | 1 |
| Sep 2027 | 1.75 | 4.72 | 1.65801 | 1.8624 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.12 | -0.098 | 0.115076B | 55.77% | 51.42M |
| FQ3 2025 (Sep 2025) | -0.31 | -0.298 | 0.060639B | 9.62% | -1.57M |
| FQ2 2025 (Jun 2025) | -0.06 | -0.28482 | 0.062236B | -13.34% | -19.75M |
| FQ1 2025 (Mar 2025) | 0.5 | 0.30344 | 0.07801B | 13.06% | 1.34M |
| FQ4 2024 (Dec 2024) | -0.57 | -0.57 | 0.050896B | -171.8% | 50.9M |
| FQ3 2024 (Sep 2024) | -0.49 | -0.49 | 0.054805B | 100% | 54.81M |
| FQ2 2024 (Jun 2024) | -7.5 | -7.5 | 0.070539B | 100% | 70.54M |
| FQ4 2017 (Dec 2017) | 0 | 0 | 0.061955B | 100% | 61.96M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.2416
Consensus Revenue Estimates
0.0858415B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.17 | -- | 0.16255 | 0.17677 | 1 |
| FQ1 2027 (Mar 2027) | 0.15 | -- | 0.14343 | 0.15597 | 1 |
| FQ4 2026 (Oct 2026) | 0.0598 | 300.67 | 0.05286204 | 0.06832408 | 0 |
| FQ3 2026 (Jul 2026) | 0.05745 | 639.6 | 0.05078468 | 0.0656391 | 0 |
| FQ2 2026 (Jun 2026) | 0.3061 | 119.6 | 0.27384 | 0.34063 | 1 |
| FQ1 2026 (Mar 2026) | 0.2416 | -106.95 | 0.21614 | 0.26885 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.07B | -- | 0.07B | 0.08B | 1 |
| FQ1 2027 (Mar 2027) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ4 2026 (Oct 2026) | 0.07B | -59.94 | 0.07B | 0.08B | 1 |
| FQ3 2026 (Jul 2026) | 0.07B | 15.19 | 0.07B | 0.08B | 1 |
| FQ2 2026 (Jun 2026) | 0.09B | 32.63 | 0.08B | 0.1B | 2 |
| FQ1 2026 (Mar 2026) | 0.09B | 9.12 | 0.08B | 0.09B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.022 | -0.12 | -0.098 | 81.67% |
| FQ3 2025 (Sep 2025) | -0.012 | -0.31 | -0.298 | 96.13% |
| FQ2 2025 (Jun 2025) | 0.22482 | -0.06 | -0.28482 | 474.7% |
| FQ1 2025 (Mar 2025) | 0.19656 | 0.5 | 0.30344 | 60.69% |
| FQ4 2024 (Dec 2024) | -0.57 | -0.57 | 100% | |
| FQ3 2024 (Sep 2024) | -0.49 | -0.49 | 100% | |
| FQ2 2024 (Jun 2024) | -7.5 | -7.5 | 100% | |
| FQ4 2017 (Dec 2017) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.06B | $0.12B | $51.42M | 44.68% |
| FQ3 2025 (Sep 2025) | $0.06B | $0.06B | $-1.57M | -2.59% |
| FQ2 2025 (Jun 2025) | $0.08B | $0.06B | $-19.75M | -31.74% |
| FQ1 2025 (Mar 2025) | $0.08B | $0.08B | $1.34M | 1.72% |
| FQ4 2024 (Dec 2024) | $0B | $0.05B | $50.9M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.05B | $54.81M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.07B | $70.54M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0.06B | $61.96M | 100% |